Nearly one in 10 Britons use or want weight-loss medication
The prevalence of GLP-1 receptor agonists for weight management in Great Britain highlights public interest and concerns over safety and prescribing practices.
Read the full articleYou might also wanna read
Internet searches on weight-loss medications have increased 25-fold since the launch of GLP-1 drugs
Public interest in obesity medication has risen 25-fold since the launch of GLP-1 receptor agonist drugs, new research presented at the Inte
Study: Over Half of Binge Eating Disorder Patients Have Used GLP-1 Weight-Loss Drugs
With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for disordered eating
mdsc.pe·17d ago
Daily weight loss pill available in UK pharmacies from today
The Wegovy tablet became the first GLP-1 pill for weight loss to be approved by the UK’s medicines regulator last month
Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption
Stronger safeguards are needed to ensure independent and transparent recommendations Glucagon-like peptide-1 (GLP-1) receptor agonists and r
bmj.com·27d ago1 in 9 Americans Now on GLP-1s
A recent Gallup poll shows that the use of GLP-1 drugs in the US has surged to a record high, with 11% of US adults currently using these me
GLP-1 Tips & Tricks
Glucagon-like peptide medications (AKA GLP-1 agonists) such as Wegovy and Zepbound are taking the weight loss industry to a whole new level.
Comments
Sign in to join the conversation.
No comments yet. Be the first.